LOC645359 Activators would represent a class of chemical compounds that target and stimulate the activity of a gene product encoded by the human gene locus LOC645359. The LOC nomenclature typically pertains to a locus for a gene product that is not well characterized or may represent a putative or predicted protein based on genomic annotation. As such, the function of the gene product of LOC645359 is likely not fully understood, and activators of this gene product would serve as investigative tools to explore its biological role. These activators would be molecular agents designed to enhance the activity of the LOC645359 protein, potentially by increasing its expression, promoting its stabilization, or facilitating its interaction with other cellular components. The process of discovering and characterizing such activators would demand a thorough understanding of the protein's structure, expression pattern, and cellular function.
The initial step in the development of LOC645359 activators would involve the establishment of a reliable assay system to measure the activity of the protein. This might involve using reporter gene assays if the protein influences transcription, enzymatic activity measurements if the protein possesses catalytic activity, or protein interaction assays if it functions in complex with other proteins. Once an assay system is in place, high-throughput screening methods could be employed to sift through large compound libraries to identify molecules that enhance the activity of LOC645359. Identified lead compounds would then undergo a battery of secondary assays to validate their activity and to rule out nonspecific effects on other proteins or cellular processes. This validation might include dose-response experiments to determine the potency of the activators and kinetic studies to assess their impact on the protein's activity over time. Subsequent studies would likely delve into the mechanistic aspects of activation, potentially involving mutagenesis of the LOC645359 protein to identify crucial residues for activator binding, or biophysical approaches such as X-ray crystallography or NMR spectroscopy to determine the mode of interaction at the molecular level. The generation of such activators would be paramount in elucidating the function of the LOC645359 gene product, providing a clearer picture of its role in the complexities of cellular biochemistry and molecular biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
By inhibiting DNA methylation, it might upregulate genes epigenetically silenced in normal tissues but active in cancers. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
An HDAC inhibitor which could lead to chromatin relaxation and potential activation of silenced genes like those in the PRAME family. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Similar to Vorinostat, as an HDAC inhibitor, it may induce expression of genes epigenetically silenced in normal tissues. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Alters proteasome activity and may influence the degradation pathways of proteins, potentially impacting PRAME family gene expression. | ||||||
6-Thioguanine | 154-42-7 | sc-205587 sc-205587A | 250 mg 500 mg | $41.00 $53.00 | 3 | |
An HDAC inhibitor that could induce hyperacetylation of histones, leading to the activation of certain genes including cancer-testis antigens. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Affects gene expression and cell differentiation, could hypothetically upregulate cancer-testis antigens like PRAME. | ||||||
Dacarbazine | 4342-03-4 | sc-219954 | 1 g | $343.00 | ||
As a chemotherapy agent, it could induce cellular stress responses that might alter the expression of various genes, including PRAME family members. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Has been shown to modulate gene expression through epigenetic mechanisms, which could include genes like those in the PRAME family. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor that can affect numerous cellular pathways, potentially leading to altered gene expression profiles. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Modulates immune response and gene expression, could potentially affect the expression of immune-related genes like PRAME. | ||||||